NO890565L - Forhindring og behandling av retroviral sykdom. - Google Patents

Forhindring og behandling av retroviral sykdom.

Info

Publication number
NO890565L
NO890565L NO89890565A NO890565A NO890565L NO 890565 L NO890565 L NO 890565L NO 89890565 A NO89890565 A NO 89890565A NO 890565 A NO890565 A NO 890565A NO 890565 L NO890565 L NO 890565L
Authority
NO
Norway
Prior art keywords
immunogen
retrovirus
hiv
infectious
useful
Prior art date
Application number
NO89890565A
Other languages
English (en)
Other versions
NO890565D0 (no
NO175846C (no
NO175846B (no
Inventor
Jonas Salk
Dennis J Carlo
Original Assignee
Immune Response Corp Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immune Response Corp Inc filed Critical Immune Response Corp Inc
Publication of NO890565D0 publication Critical patent/NO890565D0/no
Publication of NO890565L publication Critical patent/NO890565L/no
Publication of NO175846B publication Critical patent/NO175846B/no
Publication of NO175846C publication Critical patent/NO175846C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3687—Chemical treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
NO890565A 1987-06-10 1989-02-09 Fremgangsmåte for å oppnå et immunogen NO175846C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6028087A 1987-06-10 1987-06-10
US20075288A 1988-05-31 1988-05-31
PCT/US1988/001955 WO1988009670A1 (en) 1987-06-10 1988-06-09 Prevention and treatment of retroviral disease

Publications (4)

Publication Number Publication Date
NO890565D0 NO890565D0 (no) 1989-02-09
NO890565L true NO890565L (no) 1989-02-09
NO175846B NO175846B (no) 1994-09-12
NO175846C NO175846C (no) 1994-12-21

Family

ID=26739775

Family Applications (1)

Application Number Title Priority Date Filing Date
NO890565A NO175846C (no) 1987-06-10 1989-02-09 Fremgangsmåte for å oppnå et immunogen

Country Status (14)

Country Link
EP (3) EP0317622B1 (no)
JP (1) JPH0720880B2 (no)
AT (1) ATE132374T1 (no)
AU (1) AU612383B2 (no)
CA (1) CA1336407C (no)
DE (1) DE3854857T2 (no)
DK (1) DK56389A (no)
FI (1) FI95871C (no)
IL (1) IL86675A (no)
NO (1) NO175846C (no)
OA (1) OA09037A (no)
RU (1) RU2111010C1 (no)
UA (1) UA27716C2 (no)
WO (1) WO1988009670A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU620804B2 (en) * 1987-03-23 1992-02-27 Hiver Limited Novel vaccines
US5256767A (en) * 1987-06-10 1993-10-26 The Immune Response Corporation Retroviral antigens
US5227159A (en) * 1989-01-31 1993-07-13 Miller Richard A Anti-idiotype antibodies reactive with shared idiotopes expressed by B cell lymphomas and autoantibodies
WO1990015133A1 (en) * 1989-05-30 1990-12-13 Nippon Zeon Co., Ltd. Method of producing core structure of retro virus and particle produced thereby
FR2661834B1 (fr) * 1990-05-09 1995-01-27 Merieux Inst Procede de fabrication d'immunogenes de retrovirus et de vaccins contre les infections retrovirales, notamment hiv, et immunogenes et vaccins obtenus.
AU4685293A (en) * 1992-07-20 1994-02-14 Immune Response Corporation, The Prophylactic and therapeutic control of retroviral infections
ATE189697T1 (de) * 1994-03-22 2000-02-15 Immune Response Corp Inc Die hocheffiziente herstellung und isolierung von viruspartikeln
IT1271593B (it) * 1994-11-30 1997-06-04 Sanitaria Scaligera Spa Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716102A (en) * 1984-08-15 1987-12-29 Regents Of The University Of California Purified AIDS-associated virus ARV-2
DK507185A (da) * 1984-11-05 1986-05-06 Du Pont Fremgangsmaade til inaktivering af human tumor leukaemi virus iii
US4725669A (en) * 1984-11-09 1988-02-16 President And Fellows Of Harvard College Assay for detecting infection by human T-cell lymphotropic virus-III
ATE138100T1 (de) * 1984-12-24 1996-06-15 Genentech Inc Fusionen von aids-verwandten polypeptiden
ES8706824A1 (es) * 1985-04-08 1987-07-01 Genetic Systems Corp Un metodo para preparar proteinas que son inmunologicamente reactivas con anticuerpos para virus asociados con linfadenopatia.
NZ215867A (en) * 1985-04-19 1989-10-27 Hoffmann La Roche Aids envelope protein, dna vectors and method of production
WO1987002892A1 (en) * 1985-11-14 1987-05-21 President And Fellows Of Harvard College T-lymphotrophic virus
EP0250128A3 (en) * 1986-06-18 1988-06-08 American Registry of Pathology Novel virus isolated from patients with aids
WO1988007058A1 (en) * 1987-03-16 1988-09-22 Biosolutions Pty. Ltd. Anti-paratopic antibody as an immunogen

Also Published As

Publication number Publication date
DK56389D0 (da) 1989-02-08
EP0317622A4 (en) 1990-05-14
UA27716C2 (uk) 2000-10-16
FI890603A0 (fi) 1989-02-08
EP0317622A1 (en) 1989-05-31
JPH0720880B2 (ja) 1995-03-08
FI95871B (fi) 1995-12-29
OA09037A (en) 1991-03-31
JPH02500440A (ja) 1990-02-15
EP0317622B1 (en) 1996-01-03
EP0602761A1 (en) 1994-06-22
IL86675A (en) 1993-04-04
NO890565D0 (no) 1989-02-09
ATE132374T1 (de) 1996-01-15
AU1962688A (en) 1989-01-04
NO175846C (no) 1994-12-21
DE3854857T2 (de) 1996-08-22
CA1336407C (en) 1995-07-25
AU612383B2 (en) 1991-07-11
NO175846B (no) 1994-09-12
RU2111010C1 (ru) 1998-05-20
FI890603A (fi) 1989-02-08
FI95871C (fi) 1996-04-10
DE3854857D1 (de) 1996-02-15
DK56389A (da) 1989-02-08
WO1988009670A1 (en) 1988-12-15
EP0685236A1 (en) 1995-12-06

Similar Documents

Publication Publication Date Title
RU94042386A (ru) Вакцина против гепатита, содержащая 3-0-дезацилированный монофосфорил-липида, применение антигена гепатита для получения препарата для лечения гепатита, способ лечения гепатита
DE68927348D1 (de) Künstlicher impfstoff gegen aids-virus
DK1276896T3 (da) Epitop-synkronisering i antigen-præsenterende celler
EP0330359A3 (en) Composition useful in the diagnosis and treating of hiv-1 infection
HUP9801560A1 (hu) Szaponint és szterint tartalmazó vakcinák
BR0107972A (pt) Uso de uma proteìna ou polinucleotìdeo tat do hiv, nef do hiv, ou tat do hiv ligado(a) a uma proteìna ou polinucleotìdeo nef do hiv (nef-tat), e de uma proteìna ou polinucleotìdeo gp120 do hiv, método para imunizar um ser humano contra o hiv, e, composição de vacina para o uso humano
DE69426077T2 (de) Adjuvantien für impfstoffe gegen das respiratorische synzitialvirus
ATE331026T1 (de) Antigen-markierte nicht-infektiöse retrovirus- ähnlige partikel
ATE418562T1 (de) Ctl epitope des epstein-barr virus
HUP9801242A1 (hu) Hepatitis B vakcina
CY1111636T1 (el) Εμβολιο που περιεχει gp120 και nef kai/´h tat για ανοσοποιηση εναντι hiv
EP1375511A3 (en) Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus
BG98522A (en) Peptides including cytotoxic t-lymphocytic response to the virus of hepatite b
NO890565L (no) Forhindring og behandling av retroviral sykdom.
ATE188484T1 (de) Immunologisch mit hla homologe hiv protein epitope
ATE108335T1 (de) Kit oder zusammensetzung zur vorbeugung oder behandlung von hiv-1 infektionen.
DE69707680D1 (de) Caprin arthritis-enzephalitis virus enthaltende vakzine und verwendung zur immunschutz gegen hiv-1 infektion
ATE284709T1 (de) Virale chimären aus caev und hiv-1 genetischen elementen
ITRM950209A1 (it) Vaccino per la profilassiimmunitaria dell'infezione da virus della immunodeficienza felina del gatto domestico.
HUP0003511A2 (hu) Hepatitisz-B-vírus polipeptidek
ATE111485T1 (de) Peptidbehandlung von hartnäckigen infektionskrankheiten.
IT1233419B (it) Peptidi sintetici immunologicamente attivi utili per la preparazione di un vaccino antimalaria
EP0309898A3 (en) Method for the induction of a cytotoxic t cell response
RU1801212C (ru) Способ отбора детей из группы риска дл ревакцинации против кори
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов